Tag: Apellis Pharmaceuticals Inc.

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -19.76%. However, over the last six months, the performance has been stronger by -0.31%. The price of APLS decreased -14.63% over the last 30 days. And in the last five days, it has fallen by -15.50%. Apellis Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $94.75 on 06/14/23 and the lowest value was $19.83 on 08/07/23.

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Apellis Pharmaceuticals Inc’s current trading price is -40.01% away from its 52-week high, while its distance from the 52-week low is 186.63%. The stock’s price range for this time frame has been between $19.83 and $94.75. The trading volume of the company’s shares in the Healthcare reached around 0.78 million for the day, which was evidently lower than the average daily volume of 1.41 million over the last three months. In terms of market performance, Apellis Pharmaceuticals Inc had

Apellis Pharmaceuticals Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $94.75 on 06/14/23, while the lowest price for the same period was registered at $19.83 on 08/07/23. 52-week price history of APLS Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Apellis Pharmaceuticals Inc’s current trading price is -32.40% away from its 52-week high, while its distance from the 52-week low is 222.99%. The stock’s price range during the 52-week period has remained between $19.83